Source:http://linkedlifedata.com/resource/pubmed/id/11155797
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2001-1-11
|
pubmed:abstractText |
In the present prospective study, bone metabolism was examined in 51 patients at the time of diagnosis and 6-7 months later: 29 patients had definitive diagnosis of late onset rheumatoid arthritis (LORA) and 22 patients had polymyalgia rheumatica (PMR). At the time of diagnosis, the patients had not received any medication; during the 6-7 months of follow-up they were treated with corticosteroids and nonsteroidal-antirheumatic drugs (NSAIDs). Serum levels of osteocalcin, alkaline phosphatase and ostase, as markers for bone formation, were tested. Bone density was examined by dual x-ray absorption (DEXA) of the lumbar spine and the left ward triangle. At the time of diagnosis, no signs of bone alterations were seen. After 6-7 months, abnormal values of the serum parameters and bone mineral density were found in 16/51 patients (31%): 10/29 patients with LORA and 6/22 with PMR. Thus, our findings suggest that an alteration of bone metabolism could be observed in a minority of patients during the first few months of glucocorticoid medication, but in the majority of patients an osteoprotective effect seems to be worth discussing. The results suggest from a prophylactic and therapeutic point of view that an additional disease-modifying antirheumatic medication should be considered in the early stages of therapy to reduce the osteoporotic risk of a longterm corticoid therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0340-1855
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59 Suppl 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
II/137-41
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11155797-Aged,
pubmed-meshheading:11155797-Alkaline Phosphatase,
pubmed-meshheading:11155797-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:11155797-Arthritis, Rheumatoid,
pubmed-meshheading:11155797-Bone Density,
pubmed-meshheading:11155797-Bone Diseases, Metabolic,
pubmed-meshheading:11155797-Drug Therapy, Combination,
pubmed-meshheading:11155797-Female,
pubmed-meshheading:11155797-Humans,
pubmed-meshheading:11155797-Male,
pubmed-meshheading:11155797-Osteocalcin,
pubmed-meshheading:11155797-Polymyalgia Rheumatica,
pubmed-meshheading:11155797-Prednisolone
|
pubmed:year |
2000
|
pubmed:articleTitle |
Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica--a prospective study on the influence of glucocorticoid therapy.
|
pubmed:affiliation |
Kerckhoff Clinic and Foundation, Department of Rheumatology, Ludwigstr. 37-39, 61231 Bad Nauheim, Germany.
|
pubmed:publicationType |
Journal Article
|